Ophiomics
Lisboa
About Ophiomics
Ophiomics is an ISO 13485 and ISO 9001 certified, clinical-stage Medtech company developing cutting-edge diagnostic products and services integrating bioinformatics, artificial intelligence and genomics in support of diagnostic, prognostic, treatment selection and clinical follow-up in oncology. It currently has a rich pipeline of products at different development stages, from pre-clinical programs to products undergoing clinical validation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $8.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2023)
- Website: ophiomics.com
- Phone: 210 416 538
Industries & Categories
Biotechnology, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/ophiomics-68733 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.